Dr. Sandra Croak-Brossman, BioSante Pharmaceuticals

<a class="taxInlineTagLink" id="ORCRP001916" title="BioSante Pharmaceuticals Incorporated" href="/topic/economy-business-finance/biosante-pharmaceuticals-incorporated-ORCRP001916.topic">BioSante Pharmaceuticals</a>, Inc. announced the appointment of Sandra Croak-Brossman, MS, Ph.D., as Vice President, Regulatory Affairs and Quality Assurance.<br>
<br>
Dr. Croak-Brossman joins BioSante with over 24 years of experience in the pharmaceutical industry.  She has held a variety of regulatory positions and has led operations at both a U.S. and global level.  Dr. Croak-Brossman’s work experience includes positions at Boehringer Ingelheim, <a class="taxInlineTagLink" id="ORCRP012075" title="Pfizer Inc." href="/topic/economy-business-finance/pfizer-inc.-ORCRP012075.topic">Pfizer</a> and <a class="taxInlineTagLink" id="ORCRP017190" title="Abbott Laboratories" href="/topic/economy-business-finance/chemical-industry/pharmaceutical-industry/abbott-laboratories-ORCRP017190.topic">Abbott Laboratories</a>.<br>
<br>
Importantly, while at Pfizer, Dr. Croak-Brossman was the worldwide regulatory lead for Viagra.  Her experience as a regulatory lead in the sexual dysfunction therapeutic market makes her uniquely qualified to manage regulatory projects as BioSante progresses towards the NDA submission for LibiGel® (testosterone gel). Dr. Croak-Brossman earned her MS and Ph.D. in Quantitative Genetics and Animal Breeding from Purdue University and conducted her Post-Doctoral Fellowship at <a class="taxInlineTagLink" id="OREDU000066" title="Cornell University" href="/topic/education/colleges-universities/cornell-university-OREDU000066.topic">Cornell University</a>.
ct-biz-moving-sandra-croak

( August 4, 2011 )

BioSante Pharmaceuticals, Inc. announced the appointment of Sandra Croak-Brossman, MS, Ph.D., as Vice President, Regulatory Affairs and Quality Assurance.

Dr. Croak-Brossman joins BioSante with over 24 years of experience in the pharmaceutical industry. She has held a variety of regulatory positions and has led operations at both a U.S. and global level. Dr. Croak-Brossman’s work experience includes positions at Boehringer Ingelheim, Pfizer and Abbott Laboratories.

Importantly, while at Pfizer, Dr. Croak-Brossman was the worldwide regulatory lead for Viagra. Her experience as a regulatory lead in the sexual dysfunction therapeutic market makes her uniquely qualified to manage regulatory projects as BioSante progresses towards the NDA submission for LibiGel® (testosterone gel). Dr. Croak-Brossman earned her MS and Ph.D. in Quantitative Genetics and Animal Breeding from Purdue University and conducted her Post-Doctoral Fellowship at Cornell University.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook
  • Home Delivery Home Delivery

PHOTO GALLERIES

TOP VIDEO

CONNECT WITH US


2013 YEAR IN REVIEW
Look for this special section in your
Baltimore Sun newspaper on Dec. 29, 2013.
  • Twitter
  • Facebook
  • Instagram
  • Google Plus
  • RSS Feeds
  • Mobile Alerts and Apps

Contact Us | Newsroom directory | Social Sun